Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Neogen launches advanced Soleris® NG microbial testing system


LANSING, Mich., July 15, 2020 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched an advanced test system that automatically detects microorganisms in a fraction of the time of traditional testing methods.

Neogen's new Soleris® Next Generation (NG) can rapidly detect and enumerate a wide variety of microorganisms that can threaten the safety and quality of food and other consumer products. For example, Soleris NG can detect and enumerate yeast and mold in a sample in only 48 hours, as compared to the three to five days needed for traditional methods, and detects Alicyclobacillus, a bacterium of particular concern to the fruit juice industry, in only 48 hours, compared to the five days of other methods.  

"Our improved system to detect microorganisms makes it even quicker and easier for our customers to test their products and environment ? and even easier to protect their customers," said John Adent, Neogen's president and chief executive officer. "Our customers can now use a single automated system to screen consumer product and environmental samples for the presence of microorganisms ? greatly simplifying that process. This important new system can be used to test for the microorganisms of most concern to the food, nutraceutical, cosmetic and cannabis industries."

Soleris NG offers all the features, benefits and ease of use of the previous generations of the company's automated microbial testing system, and adds enhanced hardware and software to make producing, analyzing and auditing test results even easier.

The Soleris NG system provides accurate and rapid microbiological answers in a complete system approach. The system features 32-vial incubating drawers integrated with a secure software package, and each ready-to-use vial rapidly and independently detects the presence or absence of microorganisms.

The advanced Soleris NG system is validated using United States Pharmacopeia (USP) methodology to test numerous sample types, including nutraceuticals, cosmetics and cannabis products. In addition, the Soleris vials have earned multiple AOAC validations and MicroVal certifications, which allows the Soleris NG system to provide proven testing solutions all along the food and consumer goods production cycle.  

Available Soleris tests include: total viable count, yeast and mold, coliforms, E. coli, Enterobacteriaceae, Alicyclobacillus, and many more. Applications for the system include spoilage flora analysis, sterility testing, shelf-life prediction, the testing of raw materials and finished products, and others. To learn more about the new system, visit www.neogen.com.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in worldwide biosecurity products, animal genomics testing and the manufacturing and distribution of a variety of animal healthcare products, including diagnostics and veterinary instruments.

CONTACT:  

Jason Kircos, Neogen Corporation


517/372-9200, [email protected]

 

SOURCE Neogen Corporation


These press releases may also interest you

at 23:33
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...



News published on and distributed by: